COVID-19 se asocia a un mayor riesgo de desarrollar el síndrome de Guillain-Barré, un trastorno autoinmune raro pero grave, según un nuevo estudio
Related Posts
Fatal Opioid ODs Keep Rising in Black Americans
MONDAY, Sept. 13, 2021 (HealthDay News) -- The decades-long U.S. opioid epidemic...
Ultraprocessed Food Increases Risk for Death With Type 2 Diabetes
WEDNESDAY, Aug. 2, 2023 (HealthDay News) -- Higher consumption of ultraprocessed...
Child ER Visits for Swallowed Button Batteries Doubled in a Decade
MONDAY, Aug. 29, 2022 (HealthDay News) -- Trista Hamsmith’s 18-month-old...
FDA Authorizes First E-Cigarette
WEDNESDAY, Oct. 13, 2021 (HealthDay News) -- The U.S. Food and Drug...